First-in-human study with CRISPR/Cas9-based gene editing in ATTR amyloid cardiomyopathy
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Prof. Alexandre Mebazaa, MD, PhD
Eric Loucks, PhD
- AHA 2022Dramatic reduction in primary endpoint with precision testing in stable patients with suspected CAD
Prof. Pamela Douglas, MD